RKDA

#5128
Arcadia Biosciences, Inc.
1.33 USD
+0.76%
セクター: 生活必需品
ベース: USD
利益通貨: USD
日中レンジ
1.33
1.33
1年のレンジ
1.30
6.71
1日の変化
+0.76%
月次変化
-26.11%
6か月変化
-74.47%
1年の変化
-58.44%
以前の終値
1.32
始値
1.33
Bid
Ask
安値
1.33
High
1.33
ボリューム
13
チャート全体を表示

Financials

概要 明細書 統計
期次 年次
  • Market Capitalization 2.74 M
  • Employee 8
  • Founded 2002
  • CEO N/A
  • Website www.arcadiabio.com
  • Headquarter Delaware, United States
  • FIGI BBG000GYBX66
  • Industry Technology
総売上高
当期純利益
1株当たり基本利益（基本EPS）
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-1.16
売上高対価格比率
0.53

Arcadia Biosciences Inc

Arcadia Biosciences is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation. It has developed a reduced-gluten and enhanced starch variety of wheat under the name GoodWheat. Arcadia also has a joint venture with Bioceres called Verdeca, which has developed and is commercializing HB4 technology in soybeans that gained FDA approval in 2017. HB4 soybeans have increased yield up to 30% while being more resistant to abiotic stress such as drought.

ニュース